logo

For the Inventor, By the Inventor

Buffalo, NY, United States of America

Athenex, Inc.


USPTO Granted Patents = 13

% Expired Patents = 7.7



Trademarks = 7

Forward Citations = 31

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal David G Hangauer, Jr (11 out of 32 patents)

silverMedal Michael P Smolinski (5 out of 10 patents)

bronzeMedal Sameer Urgaonkar (3 out of 4 patents)

4.  Johnson Yiu-Nam Lau (2 out of 30 patents)

5.  Nader N Nasief Abdel-Sayed (2 out of 2 patents)

6.  James Lindsay Clements (2 out of 2 patents)

7.  Debasis Patra (2 out of 8 patents)

8.  Jeremy A Cody (2 out of 8 patents)

9.  Jonathon Salsbury (2 out of 7 patents)

10.  Grant Jackson Palmer (2 out of 18 patents)

11.  Paul Kenneth Isbester (2 out of 8 patents)

12.  Min-Fun Rudolf Kwan (1 out of 7 patents)

13.  E Douglas Kramer (1 out of 6 patents)

14.  David Lawrence Cutler (1 out of 6 patents)

15.  Jane Fang (1 out of 3 patents)


13 patents:

1. 11739089 - Acetamido-phenyltetrazole derivatives and methods of using the same (2023-08-29),
2. 10973828 - Biaryl compositions and methods for modulating a kinase cascade (2021-04-13),
3. 10899747 - Biaryl piperidine amide compounds and methods of use thereof (2021-01-26),
4. 10617693 - Methods of treating and/or preventing actinic keratosis (2020-04-14),
5. 10450303 - Biaryl piperidine amide compounds and methods of use thereof (2019-10-22),
6. 10323001 - Compositions for modulating a kinase cascade and methods of use thereof (2019-06-18),
7. 10213435 - Biaryl compositions and methods for modulating a kinase cascade (2019-02-26),
8. 10196357 - Biaryl compositions and methods for modulating a kinase cascade (2019-02-05),
9. 10106505 - Composition and methods for modulating a kinase cascade (2018-10-23),
10. 9926273 - Composition and methods for modulating a kinase cascade (2018-03-27),
11. 9655903 - Compositions and methods of treating cell proliferation disorders (2017-05-23),
12. 9580387 - Biaryl compositions and methods for modulating a kinase cascade (2017-02-28),
13. 9556120 - Compositions for modulating a kinase cascade and methods of use thereof (2017-01-31),
Company Overview
Athenex, Inc. is a biopharmaceutical company based in Buffalo, NY, focused on developing innovative therapies for cancer treatment. The organization specializes in leveraging its proprietary technology platforms to enhance drug delivery and improve therapeutic efficacy. Athenex's research encompasses a range of oncology-related areas, including novel formulations and combination therapies, aimed at addressing unmet medical needs in cancer care. The company is committed to advancing its pipeline through rigorous scientific exploration and collaboration.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Athenex, Inc. USPTO Patent Assignee Logo
13 Patents

#29 in Buffalo, NY

#1,377 in New York

#23,854 in US

#45,081 in the World

Buffalo, NY (US)
Buffalo, NY, United States of America

Athenex, Inc.

Forward Citations = 31

19 inventors:

goldMedal David G Hangauer, Jr (11 out of 32 patents)

silverMedal Michael P Smolinski (5 out of 10 patents)

bronzeMedal Sameer Urgaonkar (3 out of 4 patents)

4.  Johnson Yiu-Nam Lau (2 out of 30 patents)

5.  Nader N Nasief Abdel-Sayed (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Athenex, Inc.. Retrieved from https://idiyas.com/company/athenex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…